share_log

Watching Baylor BioSciences; Brookline Capital Reiterates Buy Rating, Sets $19 Price Target

Watching Baylor BioSciences; Brookline Capital Reiterates Buy Rating, Sets $19 Price Target

觀看貝勒生物科學;布魯克林資本重申購買評級,設定 19 美元目標價
Benzinga Real-time News ·  2023/01/05 11:42

Watching Baylor BioSciences; Brookline Capital Reiterates Buy Rating, Sets $19 Price Target

觀看貝勒生物科學;布魯克林資本重申購買評級,設定 19 美元目標價

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論